CTGF mediates high-glucose induced epithelial–mesenchymal transition through activation of β-catenin in podocytes

References

• Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4–14.
   PubMed Web of Science ®Google Scholar
• Jefferson JA, Shankland SJ, Pichler RH. Proteinuria in diabetic kidney disease: A mechanistic viewpoint. Kidney Int. 2008;74:22–36.
   PubMed Web of Science ®Google Scholar
• Li JJ, Kwak SJ, Jung DS, et al. Podocyte biology in diabetic nephropathy. Kidney Int. 2007;72:S36–S42.
   Google Scholar
• Reddy GR, Kotlyarevska K, Ransom RF, Menon RK. The podocyte and diabetes mellitus: Is the podocyte the key to the origins of diabetic nephropathy? Curr Opin Nephrol Hypertens. 2008;17:32–36.
   PubMed Web of Science ®Google Scholar
• Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int. 2006;69:2131–2147.
   PubMed Web of Science ®Google Scholar
• Wolf G, Chen S, Ziyadeh FN. From the periphery of the glomerular capillary wall toward the center of disease: Podocyte injury comes of age in diabetic nephropathy. Diabetes. 2005;54:1626–1634.
   PubMed Web of Science ®Google Scholar
• Li Y, Kang YS, Dai C, Kiss LP, Wen X, Liu Y. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol. 2008;172:299–308.
   PubMed Web of Science ®Google Scholar
• Liu Y. New insights into epithelial–mesenchymal transition in kidney fibrosis. J Am Soc Nephrol. 2010;21:212–222.
   PubMed Web of Science ®Google Scholar
• Reidy K, Susztak K. Epithelial–mesenchymal transition and podocyte loss in diabetic kidney disease. Am J Kidney Dis. 2009;54:590–593.
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Iwano M, Suzuki D, et al. Epithelial–mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. Am J Kidney Dis. 2009;54:653–664.
   PubMed Web of Science ®Google Scholar
• Burns WC, Thomas MC. The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology. Expert Rev Mol Med. 2010;12:e17.
   PubMed Web of Science ®Google Scholar
• Dai HY, Zheng M, Lv LL, et al. The roles of connective tissue growth factor and integrin-linked kinase in high glucose-induced phenotypic alterations of podocytes. J Cell Biochem. 2012;113:293–301.
   PubMed Web of Science ®Google Scholar
• Dai C, Stolz DB, Kiss LP, Monga SP, Holzman LB, Liu Y. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol. 2009;20:1997–2008.
   PubMed Web of Science ®Google Scholar
• Waters A, Koziell A. Activation of canonical Wnt signaling meets with podocytopathy. J Am Soc Nephrol. 2009;20:1864–1866.
   PubMed Web of Science ®Google Scholar
• He W, Dai C, Li Y, Zeng G, Monga SP, Liu Y. Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol. 2009;20:765–776.
   PubMed Web of Science ®Google Scholar
• Mundel P, Reiser J, Zuniga Mejia Borja A, et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res. 1997;236:248–258.
   PubMed Web of Science ®Google Scholar
• Zhou G, Li C, Cai L. Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway. Am J Pathol. 2004;165:2033–2043.
   PubMed Web of Science ®Google Scholar
• Fink L, Seeger W, Ermert L, et al. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med. 1998;4:1329–1333.
   PubMed Web of Science ®Google Scholar
• Diez-Sampedro A, Lenz O, Fornoni A. Podocytopathy in diabetes: A metabolic and endocrine disorder. Am J Kidney Dis. 2011;58:637–646.
   PubMed Web of Science ®Google Scholar
• Lv Z, Hu M, Zhen J, Lin J, Wang Q, Wang R. Rac1/PAK1 signaling promotes epithelial–mesenchymal transition of podocytes in vitro via triggering beta-catenin transcriptional activity under high glucose conditions. Int J Biochem Cell Biol. 2013;45:255–264.
   PubMed Web of Science ®Google Scholar
• Bradham DM, Igarashi A, Potter RL, Grotendorst GR. Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol. 1991;114:1285–1294.
   PubMed Web of Science ®Google Scholar
• Chen CC, Lau LF. Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol. 2009;41:771–783.
   PubMed Web of Science ®Google Scholar
• Leask A, Abraham DJ. All in the CCN family: Essential matricellular signaling modulators emerge from the bunker. J Cell Sci. 2006;119:4803–4810.
   PubMed Web of Science ®Google Scholar
• Mason RM. Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it? J Cell Commun Signal. 2009;3:95–104.
   PubMed Web of Science ®Google Scholar
• McLennan SV, Abdollahi M, Twigg SM. Connective tissue growth factor, matrix regulation, and diabetic kidney disease. Curr Opin Nephrol Hypertens. 2013;22:85–92.
   PubMed Web of Science ®Google Scholar
• Ito Y, Aten J, Bende RJ, et al. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int. 1998;53:853–861.
   PubMed Web of Science ®Google Scholar
• Yokoi H, Mukoyama M, Mori K, et al. Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice. Kidney Int. 2008;73:446–455.
   PubMed Web of Science ®Google Scholar
• Brigstock DR. Strategies for blocking the fibrogenic actions of connective tissue growth factor (CCN2): From pharmacological inhibition in vitro to targeted siRNA therapy in vivo. J Cell Commun Signal. 2009;3:5–18.
   PubMed Web of Science ®Google Scholar
• Xiao L, Wang M, Yang S, Liu F, Sun L. A glimpse of the pathogenetic mechanisms of Wnt/β-catenin signaling in diabetic nephropathy BioMed Res Int. 2013:2013:987064
   PubMed Web of Science ®Google Scholar
• Mercurio S, Latinkic B, Itasaki N, Krumlauf R, Smith JC. Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex. Development (Cambridge, England). 2004;131:2137–2147.
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhou KK, Ma JX. Inhibition of connective tissue growth factor overexpression in diabetic retinopathy by SERPINA3K via blocking the WNT/beta-catenin pathway. Diabetes. 2010;59:1809–1816.
   PubMed Web of Science ®Google Scholar
• Rooney B, O'Donovan H, Gaffney A, et al. CTGF/CCN2 activates canonical Wnt signalling in mesangial cells through LRP6: implications for the pathogenesis of diabetic nephropathy. FEBS Lett. 2011;585:531–538.
   PubMed Web of Science ®Google Scholar